BRITTANY CLEMMONS: Open Payments
NPI 1366808594 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 11 payments from 10 companies in 2025. Trend: 2023 $176 · 2024 $315 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, XIFAXAN, ALVESCO, INCEPTIV, VOQUEZNA, Dexcom G6 Transmitter, BREZTRI, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
